Does DEXTROAMPHETAMINE Cause Therapy partial responder? 25 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Therapy partial responder have been filed in association with DEXTROAMPHETAMINE (Zenzedi). This represents 1.2% of all adverse event reports for DEXTROAMPHETAMINE.
25
Reports of Therapy partial responder with DEXTROAMPHETAMINE
1.2%
of all DEXTROAMPHETAMINE reports
0
Deaths
24
Hospitalizations
How Dangerous Is Therapy partial responder From DEXTROAMPHETAMINE?
Of the 25 reports, 24 (96.0%) required hospitalization.
Is Therapy partial responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEXTROAMPHETAMINE. However, 25 reports have been filed with the FAERS database.
What Other Side Effects Does DEXTROAMPHETAMINE Cause?
Drug ineffective (513)
Fatigue (170)
Anxiety (169)
Product substitution issue (163)
Headache (145)
Nausea (130)
Off label use (121)
Somnolence (110)
Feeling abnormal (108)
Product availability issue (106)
What Other Drugs Cause Therapy partial responder?
CYCLOPHOSPHAMIDE (1,397)
RITUXIMAB (1,219)
DEXAMETHASONE (1,199)
PREDNISONE (1,176)
PEMBROLIZUMAB (1,125)
CARBOPLATIN (1,096)
DOXORUBICIN (834)
METHOTREXATE (775)
VINCRISTINE (707)
ETOPOSIDE (670)
Which DEXTROAMPHETAMINE Alternatives Have Lower Therapy partial responder Risk?
DEXTROAMPHETAMINE vs DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE AND AMPHETAMINE
DEXTROAMPHETAMINE vs DEXTROMETHORPHAN
DEXTROAMPHETAMINE vs DEXTROMETHORPHAN HYDROBROMIDE
DEXTROAMPHETAMINE vs DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN
DEXTROAMPHETAMINE vs DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN\PHENYLEPHRINE